|
 Researchers studied what's known as mindfulness-based cognitive
therapy, a combination of group counseling sessions and meditation
exercises. For people with a history of severe depression,
researchers found that replacing drugs with this type of therapy
might work as well as continued treatment with medication.
These findings add to a growing body of evidence that suggests group
therapy can successfully keep depression symptoms in check, said Dr.
William Marchand, a psychiatrist at the University of Utah who
wasn't involved in the study.
"Antidepressants are the gold standard for the prevention of relapse
of depression," Marchand said by email. The findings, he said, show
that "mindfulness-based cognitive therapy is an important
intervention for the prevention of depressive relapse and equal to
the gold standard."
The study led by Willem Kuyken, of the University of Oxford in the
U.K., recruited 424 people aged 18 years and older with at least
three previous episodes of severe depression and who were currently
taking drugs for the disorder.
Half of the study participants kept taking medication for two years,
while the other half switched to mindfulness-based cognitive
therapy. Patients assigned to the cognitive therapy received support
from doctors or therapists to gradually reduce or discontinue
medication.
The mindfulness-based therapy included eight weekly group sessions,
followed by a year of sessions once every three months. Through
group instruction and take-home assignments, participants learned to
mediate and become more aware of physical and emotional sensations
that might be associated with a relapse.
Among the 366 participants still in the study after two years, 94
assigned to the therapy group and 100 of those on antidepressants
had experienced a relapse of their depression, a difference between
groups small enough that it could have been due to chance.
Researchers also found no differences based on the severity of
depression at the start of the study.
One limitation of the study is its lack of a control group of
patients who received neither therapy nor drugs, the study authors
write in The Lancet.
"The good news of the trial is that mindfulness-based cognitive
therapy may be a viable alternative to antidepressant medication as
a long-term treatment strategy," Stephan Hofmann, director of the
Social Anxiety Program at the Center for Anxiety and Related
Disorders at Boston University, said by email.
[to top of second column] |
"The bad news is that we can't be certain about these results
because there was no control group," added Hofmann, who wasn't
involved in the study.
Even so, the finding that both alternatives studied may be
comparable has "substantial clinical significance," Dr. Roger Mulder,
a psychologist at the University of Otago in New Zealand, wrote in
an editorial accompanying the study.
The findings "provide evidence that mindfulness-based cognitive
therapy might offer a similar ongoing protective effect as that of
maintenance antidepressants," Mulder wrote.
Therapy may have worked because at the start of the study, patients
were already on drugs that had produced a large reduction in their
symptoms, said Daniel Strunk, a psychology professor at Ohio State
University in Columbus who wasn't involved in the study. Some
patients may only benefit from therapy if they remain on medication
at the same time, he said by email.
More research is needed to pinpoint which people might be more
likely to benefit from therapy or from medication, said Steven
Hollon, a psychology professor at Vanderbilt University in
Tennessee.
"It's pretty clear that mindfulness can have an effect," Hollon
said. "We are just beginning to understand how this may become a
viable alternative to medication particularly for people who don't
want to stay on medication forever."
SOURCE: http://bit.ly/1AmCYU7
The Lancet, online April 21, 2015.
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
